Study points to possible treatments and confirms distinction between memory loss due to aging and that of Alzheimer’s
A team of Columbia University Medical Center (CUMC) researchers, led by Nobel laureate Eric R. Kandel, MD, has found that deficiency of a protein called RbAp48 in the hippocampus is a significant contributor to age-related memory loss and that this form of memory loss is reversible. The study, conducted in postmortem human brain cells and in mice, also offers the strongest causal evidence that age-related memory loss and Alzheimer’s disease are distinct conditions. The findings were published today in the online edition of Science Translational Medicine.
“Our study provides compelling evidence that age-related memory loss is a syndrome in its own right, apart from Alzheimer’s. In addition to the implications for the study, diagnosis, and treatment of memory disorders, these results have public health consequences,” said Dr. Kandel, who is University Professor & Kavli Professor of Brain Science, co-director of Columbia’s Mortimer B. Zuckerman Mind Brain Behavior Institute, director of the Kavli Institute for Brain Science, and senior investigator, Howard Hughes Medical Institute, at CUMC. Dr. Kandel received a share of the 2000 Nobel Prize in Physiology or Medicine for his discoveries related to the molecular basis of memory.
The hippocampus, a brain region that consists of several interconnected subregions, each with a distinct neuron population, plays a vital role in memory. Studies have shown that Alzheimer’s disease hampers memory by first acting on the entorhinal cortex (EC), a brain region that provides the major input pathways to the hippocampus. It was initially thought that age-related memory loss is an early manifestation of Alzheimer’s, but mounting evidence suggests that it is a distinct process that affects the dentate gyrus (DG), a subregion of the hippocampus that receives direct input from the EC.
“Until now, however, no one has been able to identify specific molecular defects involved in age-related memory loss in humans,” said co-senior author Scott A. Small, MD, the Boris and Rose Katz Professor of Neurology and director of the Alzheimer’s Research Center at CUMC.
The current study was designed to look for more direct evidence that age-related memory loss differs from Alzheimer’s disease. The researchers began by performing microarray (gene expression) analyses of postmortem brain cells from the DG of eight people, ages 33 to 88, all of whom were free of brain disease. The team also analyzed cells from their EC, which served as controls since that brain structure is unaffected by aging. The analyses identified 17 candidate genes that might be related to aging in the DG. The most significant changes occurred in a gene called RbAp48, whose expression declined steadily with aging across the study subjects.
To determine whether RbAp48 plays an active role in age-related memory loss, the researchers turned to mouse studies. “The first question was whether RbAp48 is downregulated in aged mice,” said lead author Elias Pavlopoulos, PhD, associate research scientist in neuroscience at CUMC. “And indeed, that turned out to be the case—there was a reduction of RbAp48 protein in the DG.”
When the researchers genetically inhibited RbAp48 in the brains of healthy young mice, they found the same memory loss as in aged mice, as measured by novel object recognition and water maze memory tests. When RbAp48 inhibition was turned off, the mice’s memory returned to normal.
The researchers also did functional MRI (fMRI) studies of the mice with inhibited RbAp48 and found a selective effect in the DG, similar to that seen in fMRI studies of aged mice, monkeys, and humans. This effect of RbAp48 inhibition on the DG was accompanied by defects in molecular mechanisms similar to those found in aged mice. The fMRI profile and mechanistic defects of the mice with inhibited RbAp48 returned to normal when the inhibition was turned off.
In another experiment, the researchers used viral gene transfer and increased RbAp48expression in the DG of aged mice. “We were astonished that not only did this improve the mice’s performance on the memory tests, but their performance was comparable to that of young mice,” said Dr. Pavlopoulos.
“The fact that we were able to reverse age-related memory loss in mice is very encouraging,” said Dr. Kandel. “Of course, it’s possible that other changes in the DG contribute to this form of memory loss. But at the very least, it shows that this protein is a major factor, and it speaks to the fact that age-related memory loss is due to a functional change in neurons of some sort. Unlike with Alzheimer’s, there is no significant loss of neurons.”
The Latest on: Age-Related Memory Loss
- Yale tests aging doctors with memory tests to keep patients safe, many asked to retireon January 25, 2020 at 11:30 am
Those figures have led to more questions after a new report shows that many aging doctors are experiencing significant memory loss. A group of researchers ... a variety of neurocognitive tests to ...
- Scientists have created a drug that prevents Alzheimer's in mice by boosting levels of a proteinon January 21, 2020 at 7:41 pm
It works by boosting levels of a protein that clears the brain of rogue proteins that cause memory loss and confusion. Research conducted on mice engineered to develop the age-related disease showed ...
- Having a bigger brain does NOT mean you have a better memory, study findson January 21, 2020 at 6:53 am
Past research has shown that the hippocampus shrinks with age and may be linked to memory loss in pensioners and people with ... Our findings reinforce a growing perspective that studying age-related ...
- Delaying memory decline: different options and emerging solutionson January 21, 2020 at 6:22 am
In neurodegenerative disease, there are therapies that treat the symptoms of memory loss, while others attack the fundamental disease ... MOL exactly succeed in enhancing human memory and if they ...
- Age-related memory losson January 20, 2020 at 2:41 pm
Memory loss may be due to natural ageing, a side effect of medication or an indication of something more serious, such as a dementia-related illness. Our brains store huge amounts of information ...
- 13% of the doctors found to have severe memory impairments, study revealson January 18, 2020 at 6:30 pm
And those figures have led to more questions after a new report shows that many aging doctors are experiencing significant memory loss. A group of researchers ... variety of neurocognitive tests to ...
- Many aging doctors undergo memory tests to keep patients safeon January 18, 2020 at 11:03 am
And those figures have led to more questions after a new report shows that many aging doctors are experiencing significant memory loss ... tests to detect age-related memory problems.
- Aging doctors undergo memory tests to keep patients safeon January 18, 2020 at 10:08 am
A group of researchers at Yale University presented results from a three-year program where doctors over the age of 70 were tested for memory skills.
- Over 50? Resolve to Check Your Hearingon January 16, 2020 at 4:28 pm
As we consider resolutions in this new year, make sure getting your hearing checked by a hearing care professional is a top priority – especially if you are over 50 years old. According to a recent ...
- Free memory screenings offered this month for those 75 and olderon January 3, 2020 at 11:09 am
Age-related cognitive decline is a normal part of getting older. But age-related memory loss is not the same as dementia. When an older person experiences the former, they may forget where they ...
via Google News and Bing News